![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (141)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Mauro Giovanni Carta, Pasquale Paribello, Annalisa Anastasia, Domenico De Berardis, Antonio Egidio Nardi & Michele Fornaro. (2018) Pharmacological management of depression in patients with multiple sclerosis. Expert Opinion on Pharmacotherapy 19:14, pages 1533-1540.
Read now
Read now
Michael H. Andreae, Evelyn Rhodes, Tyler Bourgoise, George M. Carter, Robert S. White, Debbie Indyk, Henry Sacks & Rosamond Rhodes. (2016) An Ethical Exploration of Barriers to Research on Controlled Drugs. The American Journal of Bioethics 16:4, pages 36-47.
Read now
Read now
Igor Kissin. (2015) Scientometrics of drug discovery efforts: pain-related molecular targets. Drug Design, Development and Therapy 9, pages 3393-3404.
Read now
Read now
Travis D. Satterlund, Juliet P. Lee & Roland S. Moore. (2015) Stigma among California’s Medical Marijuana Patients. Journal of Psychoactive Drugs 47:1, pages 10-17.
Read now
Read now
Mellar P Davis. (2014) Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands. Expert Opinion on Investigational Drugs 23:8, pages 1123-1140.
Read now
Read now
Eva de Lago, María Gómez-Ruiz, Miguel Moreno-Martet & Javier Fernández-Ruiz. (2009) Cannabinoids, multiple sclerosis and neuroprotection. Expert Review of Clinical Pharmacology 2:6, pages 645-660.
Read now
Read now
Sara N. Davison & Charles J. Ferro. (2009) Management of pain in chronic kidney disease. Progress in Palliative Care 17:4, pages 186-195.
Read now
Read now
Peter J. Cohen. (2009) Medical Marijuana: The Conflict Between Scientific Evidence and Political Ideology. Part Two of Two. Journal of Pain & Palliative Care Pharmacotherapy 23:2, pages 120-140.
Read now
Read now
Jordi Perez & Mª Victoria Ribera. (2008) Managing neuropathic pain with Sativex®: a review of its pros and cons. Expert Opinion on Pharmacotherapy 9:7, pages 1189-1195.
Read now
Read now
Mellar P Davis. (2008) Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain. Expert Opinion on Investigational Drugs 17:1, pages 85-95.
Read now
Read now
Simon Haroutiunian, Gila Rosen, Rivka Shouval & Elyad Davidson. (2008) Open-Label, Add-on Study of Tetrahydrocannabinol for Chronic Nonmalignant Pain. Journal of Pain & Palliative Care Pharmacotherapy 22:3, pages 213-217.
Read now
Read now
Natalya M. Kogan & Raphael Mechoulam. (2007) Cannabinoids in health and disease. Dialogues in Clinical Neuroscience 9:4, pages 413-430.
Read now
Read now
Articles from other publishers (129)
Libak Abou, Daniel Whibley, Daniel J. Clauw & Anna L. Kratz. (2023) Widespread Pain With Nociplastic Features is an Independent Predictor of Low Physical Activity in People with Multiple Sclerosis. The Journal of Pain.
Crossref
Crossref
Diana Persia, Francesca Mangiavacchi, Maria Carla Marcotullio & Ornelio Rosati. (2023) Cannabinoids as multifaceted compounds. Phytochemistry 212, pages 113718.
Crossref
Crossref
Michael C Ferraro, Aidan G Cashin, Benedict M Wand, Keith M Smart, Carolyn Berryman, Louise Marston, G Lorimer Moseley, James H McAuley & Neil E O'Connell. (2023) Interventions for treating pain and disability in adults with complex regional pain syndrome- an overview of systematic reviews. Cochrane Database of Systematic Reviews 2023:6.
Crossref
Crossref
Alan D. BellCaroline MacCallum, Shari MargoleseZach WalshPatrick WrightPaul J. DaeninckEnrico MandarinoGary Lacasse, Jagpaul Kaur DeolLauren de FreitasMichelle St. Pierre, Lynne Belle-IsleMarilou GagnonSian BevanTatiana SanchezStephanie ArltMax Monahan-EllisonJames O'HaraMichael BoivinCecilia Costiniuk, Nancy Chow, Rob Sealey & Lynda Balneaves. (2023) Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions. Cannabis and Cannabinoid Research.
Crossref
Crossref
Jehad Barakji, Steven Kwasi Korang, Joshua Feinberg, Mathias Maagaard, Ole Mathiesen, Christian Gluud & Janus Christian Jakobsen. (2023) Cannabinoids versus placebo for pain: A systematic review with meta-analysis and Trial Sequential Analysis. PLOS ONE 18:1, pages e0267420.
Crossref
Crossref
Thorsten Rudroff & Craig D. Workman. 2023. Cannabis Use, Neurobiology, Psychology, and Treatment. Cannabis Use, Neurobiology, Psychology, and Treatment
301
312
.
Ivan A. RossIvan A. Ross. 2023. Plant-Based Therapeutics, Volume 1. Plant-Based Therapeutics, Volume 1
363
426
.
Abdel-ilah AzizLong Chi NguyenLoubna OumeslakhtArmand BensussanSanae Ben Mkaddem. (2022) Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations. Cannabis and Cannabinoid Research.
Crossref
Crossref
Henning T. Langer, Alec AveyKeith Baar. (2022)
Cannabidiol Does Not Impact Acute Anabolic or Inflammatory Signaling in Skeletal Muscle
In Vitro
. Cannabis and Cannabinoid Research 7:5, pages 628-636.
Crossref
Crossref
D. Scuteri, F. Guida, S. Boccella, L. Luongo, S. Maione, P. Tonin, P. Nicotera, G. Bagetta & M.T. Corasaniti. (2022) NAbiximols Clinical Translation To the treatment of Pain and Agitation In Severe Dementia (NACTOPAISD): Clinical trial protocol. Biomedicine & Pharmacotherapy 153, pages 113488.
Crossref
Crossref
Markus Köstenberger, Gerhard Nahler, Trevor M. Jones, Stefan Neuwersch & Rudolf Likar. (2021) The Role of Cannabis, Cannabidiol and Other Cannabinoids in Chronic Pain. The Perspective of Physicians. Journal of Neuroimmune Pharmacology 17:1-2, pages 318-333.
Crossref
Crossref
Fatma Haddad, Ghadeer Dokmak & Rafik Karaman. (2022) The Efficacy of Cannabis on Multiple Sclerosis-Related Symptoms. Life 12:5, pages 682.
Crossref
Crossref
Thomas J. P. Mangnus, Krishna D. Bharwani, Maaike Dirckx & Frank J. P. M. Huygen. (2022) From a Symptom-Based to a Mechanism-Based Pharmacotherapeutic Treatment in Complex Regional Pain Syndrome. Drugs 82:5, pages 511-531.
Crossref
Crossref
Seema Devi, Amy M. Zimmermann-Klemd, Bernd L. Fiebich, Michael Heinrich, Carsten Gründemann, Peter Steinberger, Stefanie Kowarschik & Roman Huber. (2022) Immunosuppressive activity of non-psychoactive Cannabis sativa L. extract on the function of human T lymphocytes. International Immunopharmacology 103, pages 108448.
Crossref
Crossref
Christopher A. Legare, Wesley M. Raup-Konsavage & Kent E. Vrana. (2022) Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals. Pharmacology 107:3-4, pages 131-149.
Crossref
Crossref
Camila Pantoja-Ruiz, Paula Restrepo-Jimenez, Camilo Castañeda-Cardona, Alexandra Ferreirós & Diego Rosselli. (2022) Cannabis and pain: a scoping review. Brazilian Journal of Anesthesiology (English Edition) 72:1, pages 142-151.
Crossref
Crossref
Nadire Özenver. 2022. Cannabis/Marijuana for Healthcare. Cannabis/Marijuana for Healthcare
131
154
.
Rachel Riera, Rafael Leite Pacheco, Ângela Maria Bagattini & Ana Luiza Cabrera Martimbianco. (2021) Efficacy and safety of therapeutic use of cannabis derivatives and their synthetic analogs: Overview of systematic reviews. Phytotherapy Research 36:1, pages 5-21.
Crossref
Crossref
Vidyasagar Naik Bukke, Moola Archana, Rosanna Villani, Gaetano Serviddio & Tommaso Cassano. (2021) Pharmacological and Toxicological Effects of Phytocannabinoids and Recreational Synthetic Cannabinoids: Increasing Risk of Public Health. Pharmaceuticals 14:10, pages 965.
Crossref
Crossref
R. Andrew Moore, Emma Fisher, David P. Finn, Nanna B. Finnerup, Ian Gilron, Simon Haroutounian, Elliot Krane, Andrew S.C. Rice, Michael Rowbotham, Mark Wallace & Christopher Eccleston. (2021) Cannabinoids, cannabis, and cannabis-based medicines for pain management: an overview of systematic reviews. Pain 162:1, pages S67-S79.
Crossref
Crossref
Anna L. Kratz, Daniel Whibley, Kevin N. Alschuler, Dawn M. Ehde, David A. Williams, Daniel J. Clauw & Tiffany J. Braley. (2021) Characterizing chronic pain phenotypes in multiple sclerosis: a nationwide survey study. Pain 162:5, pages 1426-1433.
Crossref
Crossref
Igor Dykukha, Rolf Malessa, Ute Essner & Michael A Überall. (2021) Nabiximols in Chronic Neuropathic Pain: A Meta-Analysis of Randomized Placebo-Controlled Trials. Pain Medicine 22:4, pages 861-874.
Crossref
Crossref
Henning T. Langer, Agata A. Mossakowski, Suraj Pathak, Mark Mascal & Keith Baar. (2021) Cannabidiol Does Not Impair Anabolic Signaling Following Eccentric Contractions in Rats. International Journal of Sport Nutrition and Exercise Metabolism 31:2, pages 93-100.
Crossref
Crossref
Joshua Aviram, Dorit Pud, Tamar Gershoni, Bareket Schiff‐Keren, Miriam Ogintz, Simon Vulfsons, Tamar Yashar, Haim‐Moshe Adahan, Silviu Brill, Howard Amital, Itay Goor‐Aryeh, Dror Robinson, Leslie Green, Refael Segal, Yacov Fogelman, Oren Tsvieli, Ben Yellin, Yelena Vysotski, Ofir Morag, Vadim Tashlykov, Roee Sheinfeld, Ruth Goor, David Meiri & Elon Eisenberg. (2020) Medical cannabis treatment for chronic pain: Outcomes and prediction of response. European Journal of Pain 25:2, pages 359-374.
Crossref
Crossref
Caroline A. MacCallum, Lauren Eadie & Samer N. Narouze. 2021. Cannabinoids and Pain. Cannabinoids and Pain
205
210
.
Michael Suer & Nalini SehgalMichael Suer & Nalini Sehgal. 2021. Questions and Answers in Pain Medicine. Questions and Answers in Pain Medicine
249
254
.
Garth E. Terry, Vanessa Raymont & Andrew G. Horti. 2021. PET and SPECT of Neurobiological Systems. PET and SPECT of Neurobiological Systems
319
426
.
Tanja Schlereth. (2020) Guideline “diagnosis and non interventional therapy of neuropathic pain” of the German Society of Neurology (deutsche Gesellschaft für Neurologie). Neurological Research and Practice 2:1.
Crossref
Crossref
Nadia Montero-Oleas, Ingrid Arevalo-Rodriguez, Solange Nuñez-González, Andrés Viteri-García & Daniel Simancas-Racines. (2020) Therapeutic use of cannabis and cannabinoids: an evidence mapping and appraisal of systematic reviews. BMC Complementary Medicine and Therapies 20:1.
Crossref
Crossref
Stanley Sau Ching Wong, Wing Shing Chan & Chi Wai Cheung. (2020) Analgesic Effects of Cannabinoids for Chronic Non-cancer Pain: a Systematic Review and Meta-Analysis with Meta-Regression. Journal of Neuroimmune Pharmacology 15:4, pages 801-829.
Crossref
Crossref
L. Briand Madrid, C. Donadille, V. Martin, L. Appel, M. Le Brun Gadelius, S. Mezaache & P. Roux. (2020) Enquête CANNAVID : Modifications de la consommation de cannabis chez les usagers quotidiens en période de pandémie de Covid-19. Psychotropes Vol. 26:2, pages 141-163.
Crossref
Crossref
Óscar Fernández, Lucienne Costa-Frossard, Marisa Martínez-Ginés, Paloma Montero, José Maria Prieto & Lluis Ramió. (2020) The Broad Concept of “Spasticity-Plus Syndrome” in Multiple Sclerosis: A Possible New Concept in the Management of Multiple Sclerosis Symptoms. Frontiers in Neurology 11.
Crossref
Crossref
Elisabeth Schneider-Smith, Kristin Salottolo, Claire Swartwood, Casey Melvin, Robert M Madayag & David Bar-Or. (2020) Matched pilot study examining cannabis-based dronabinol for acute pain following traumatic injury. Trauma Surgery & Acute Care Open 5:1, pages e000391.
Crossref
Crossref
Karma Rabgay, Neti Waranuch, Nathorn Chaiyakunapruk, Ratree Sawangjit, Kornkanok Ingkaninan & Piyameth Dilokthornsakul. (2020) The effects of cannabis, cannabinoids, and their administration routes on pain control efficacy and safety: A systematic review and network meta-analysis. Journal of the American Pharmacists Association 60:1, pages 225-234.e6.
Crossref
Crossref
Roy Upton. 2020. Textbook of Natural Medicine. Textbook of Natural Medicine
470
483.e5
.
Tanja Schlereth. (2019) S2k-Leitlinie: Diagnose und nicht interventionelle Therapie neuropathischer SchmerzenS2k Guidelines: Diagnosis and Non-Interventional Treatment of Neuropathic Pain. DGNeurologie 3:1, pages 21-40.
Crossref
Crossref
Debojyoti Bag, Aliya Tabassum, Nidhi Arora, Praveen Kumar Verma & Sanghapal D. Sawant. 2020. Botanical Leads for Drug Discovery. Botanical Leads for Drug Discovery
201
241
.
Robert S. Ackerman, Frederick Li, Tom Mario Davis & Nathaniel Loo. 2020. Pain Management for Clinicians. Pain Management for Clinicians
141
174
.
Misty Pratt, Adrienne Stevens, Micere Thuku, Claire Butler, Becky Skidmore, L. Susan Wieland, Mark Clemons, Salmaan Kanji & Brian Hutton. (2019) Benefits and harms of medical cannabis: a scoping review of systematic reviews. Systematic Reviews 8:1.
Crossref
Crossref
Josianna Schwan, Joseph Sclafani & Vivianne L. Tawfik. (2019) Chronic Pain Management in the Elderly. Anesthesiology Clinics 37:3, pages 547-560.
Crossref
Crossref
Eva Hoch, Chris Friemel, Miriam Schneider, Oliver Pogarell, Alkomiet Hasan & Ulrich W. Preuss. (2019) Wirksamkeit und Sicherheit von Cannabisarzneimitteln: Ergebnisse der CaPRis-StudieEfficacy and safety of medicinal cannabis: results of the CaPRis study. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 62:7, pages 825-829.
Crossref
Crossref
Mitchell Oakes, Wen Jing Law & Richard Komuniecki. (2019)
Cannabinoids Stimulate the TRP Channel-Dependent Release of Both Serotonin and Dopamine to Modulate Behavior in
C. elegans
. The Journal of Neuroscience 39:21, pages 4142-4152.
Crossref
Crossref
Eva Hoch, Miriam Schneider, Rupert von Keller, Udo Bonnet, Peter Falkai, Alkomiet Hasan, Winfried Häuser, Burkhard Hinz, Luise Jakob, Johannes Kabisch, Ludwig Kraus, Dominik Niemann, Frank Petzke, Oliver Pogarell, Ulrich Preuss, Lukas Radbruch, Nina Sarubin, Kathrin Schacherbauer, Michael Schäfer, Martin Storr & Chris Maria Friemel. 2019. Cannabis: Potenzial und Risiko. Cannabis: Potenzial und Risiko
265
426
.
Md Ruhul Amin & Declan W. Ali. 2019. Recent Advances in Cannabinoid Physiology and Pathology. Recent Advances in Cannabinoid Physiology and Pathology
151
165
.
Mari Carmen Torres-Moreno, Esther Papaseit, Marta Torrens & Magí Farré. (2018) Assessment of Efficacy and Tolerability of Medicinal Cannabinoids in Patients With Multiple Sclerosis. JAMA Network Open 1:6, pages e183485.
Crossref
Crossref
Kara Manning, Andrew H. Rogers, Jafar Bakhshaie, Julianna B.D. Hogan, Julia D. Buckner, Joseph W. Ditre & Michael J. Zvolensky. (2018) The association between perceived distress tolerance and cannabis use problems, cannabis withdrawal symptoms, and self-efficacy for quitting cannabis: The explanatory role of pain-related affective distress. Addictive Behaviors 85, pages 1-7.
Crossref
Crossref
Dvory Namdar, Moran Mazuz, Aurel Ion & Hinanit Koltai. (2018) Variation in the compositions of cannabinoid and terpenoids in Cannabis sativa derived from inflorescence position along the stem and extraction methods. Industrial Crops and Products 113, pages 376-382.
Crossref
Crossref
Omar I. Halawa, Timothy J. Furnish & Mark S. Wallace. 2018. Essentials of Pain Medicine. Essentials of Pain Medicine
509
520.e2
.
Melanie B Elliott, Sara J Ward, Mary E Abood, Ronald F Tuma & Jack I Jallo. (2017) Understanding the endocannabinoid system as a modulator of the trigeminal pain response to concussion. Concussion 2:4, pages CNC49.
Crossref
Crossref
Howard MengBradley JohnstonMarina EnglesakisDwight E. MoulinAnuj Bhatia. (2017) Selective Cannabinoids for Chronic Neuropathic Pain: A Systematic Review and Meta-analysis. Anesthesia & Analgesia 125:5, pages 1638-1652.
Crossref
Crossref
Jasmine Turna, Beth Patterson & Michael Van Ameringen. (2017) Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?. Depression and Anxiety 34:11, pages 1006-1017.
Crossref
Crossref
Rubén F. Allende-Salazar & Gabriel Rada. (2017) Are cannabinoids an effective treatment for chronic non-cancer pain?. Medwave 17:Suppl2, pages e6972-e6972.
Crossref
Crossref
Sharon R. Sznitman. (2017) Do recreational cannabis users, unlicensed and licensed medical cannabis users form distinct groups?. International Journal of Drug Policy 42, pages 15-21.
Crossref
Crossref
Mitchell D. Oakes, Wen Jing Law, Tobias Clark, Bruce A. Bamber & Richard Komuniecki. (2017)
Cannabinoids Activate Monoaminergic Signaling to Modulate Key
C. elegans
Behaviors
. The Journal of Neuroscience 37:11, pages 2859-2869.
Crossref
Crossref
Geir Smedslund, Sabine Wollscheid, Lin Fang, Wendy Nilsen, Asbjørn Steiro & Lillebeth Larun. (2017) Effects of early, computerized brief interventions on risky alcohol use and risky cannabis use among young people. Campbell Systematic Reviews 13:1, pages 1-192.
Crossref
Crossref
Katarzyna Starowicz & David P. Finn. 2017. Cannabinoid Pharmacology. Cannabinoid Pharmacology
437
475
.
M. Mecha, A. Feliú, F.J. Carrillo-Salinas & C. Guaza. 2017. Handbook of Cannabis and Related Pathologies. Handbook of Cannabis and Related Pathologies
893
904
.
Evelyn Rhodes, Michael Andreae, Tyler Bourgiose, Debbie Indyk, Rosamond Rhodes & Henry Sacks. (2016) Stakeholders’ Views on Barriers to Research on Controlled Substances. The Journal of Clinical Ethics 27:4, pages 308-321.
Crossref
Crossref
Ernest Small. 2016. Cannabis. Cannabis
229
252
.
Barth Wilsey, Thomas D. Marcotte, Reena Deutsch, Holly Zhao, Hannah Prasad & Amy Phan. (2016) An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain From Spinal Cord Injury and Disease. The Journal of Pain 17:9, pages 982-1000.
Crossref
Crossref
Jayesh R. Parmar, Benjamin D. Forrest & Robert A. Freeman. (2016) Medical marijuana patient counseling points for health care professionals based on trends in the medical uses, efficacy, and adverse effects of cannabis-based pharmaceutical drugs. Research in Social and Administrative Pharmacy 12:4, pages 638-654.
Crossref
Crossref
Daniel Feingold, Itay Goor-Aryeh, Silviu Bril, Yael Delayahu & Shaul Lev-Ran. (2016) Problematic Use of Prescription Opioids and Medicinal Cannabis Among Patients Suffering from Chronic Pain. Pain Medicine, pages pnw134.
Crossref
Crossref
Suzanne H. Gage, Matthew Hickman & Stanley Zammit. (2016) Association Between Cannabis and Psychosis: Epidemiologic Evidence. Biological Psychiatry 79:7, pages 549-556.
Crossref
Crossref
Margherita Russo, Antonino Naro, Antonino Leo, Edoardo Sessa, Giangaetano D’Aleo, Placido Bramanti & Rocco Salvatore Calabrò. (2016)
Evaluating Sativex
®
in Neuropathic Pain Management: A Clinical and Neurophysiological Assessment in Multiple Sclerosis
. Pain Medicine, pages pnv080.
Crossref
Crossref
Mariana Babayeva, Haregewein Assefa, Paramita Basu, Sanjeda Chumki & Zvi Loewy. (2016) Marijuana Compounds: A Nonconventional Approach to Parkinson’s Disease Therapy. Parkinson's Disease 2016, pages 1-19.
Crossref
Crossref
Timothy Furnish & Mark Wallace. 2016. Controlled Substance Management in Chronic Pain. Controlled Substance Management in Chronic Pain
87
109
.
Michael H. Andreae, George M. Carter, Naum Shaparin, Kathryn Suslov, Ronald J. Ellis, Mark A. Ware, Donald I. Abrams, Hannah Prasad, Barth Wilsey, Debbie Indyk, Matthew Johnson & Henry S. Sacks. (2015) Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data. The Journal of Pain 16:12, pages 1221-1232.
Crossref
Crossref
Matthew W. Elmes, Martin Kaczocha, William T. Berger, KwanNok Leung, Brian P. Ralph, Liqun Wang, Joseph M. Sweeney, Jeremy T. Miyauchi, Stella E. Tsirka, Iwao Ojima & Dale G. Deutsch. (2015) Fatty Acid-binding Proteins (FABPs) Are Intracellular Carriers for Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD). Journal of Biological Chemistry 290:14, pages 8711-8721.
Crossref
Crossref
Elizabeth Hahn & Brian Burrell. (2015) Pentylenetetrazol-induced seizure-like behavior and neural hyperactivity in the medicinal leech. Invertebrate Neuroscience 15:1.
Crossref
Crossref
Jørgen G. Bramness. (2015) Cannabis som medisin. Tidsskrift for Den norske legeforening 135:3, pages 252-253.
Crossref
Crossref
Perry G. Fine & Mark J. Rosenfeld. (2014) Cannabinoids for Neuropathic Pain. Current Pain and Headache Reports 18:10.
Crossref
Crossref
A.-L. Klauke, I. Racz, B. Pradier, A. Markert, A.M. Zimmer, J. Gertsch & A. Zimmer. (2014) The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain. European Neuropsychopharmacology 24:4, pages 608-620.
Crossref
Crossref
G.A.H. van den Elsen, A.I.A. Ahmed, M. Lammers, C. Kramers, R.J. Verkes, M.A. van der Marck & M.G.M. Olde Rikkert. (2014) Efficacy and safety of medical cannabinoids in older subjects: A systematic review. Ageing Research Reviews 14, pages 56-64.
Crossref
Crossref
Ahmed Toosy, Olga Ciccarelli & Alan Thompson. 2014. Multiple Sclerosis and Related Disorders. Multiple Sclerosis and Related Disorders
513
562
.
Rajesh GuptaRajesh Gupta. 2014. Pain Management. Pain Management
55
56
.
Andrew G. Horti, Vanessa Raymont & Garth E. Terry. 2014. PET and SPECT of Neurobiological Systems. PET and SPECT of Neurobiological Systems
249
319
.
Sabine Wollscheid, Lin Fang, Wendy Nilsen, Geir Smedslund, Asbjørn Steiro, Karianne Thune Hammerstrøm & Lillebeth Larun. (2014) PROTOCOL: Effect of early, brief computerized interventions on risky alcohol use and risky cannabis use among young people: protocol for a systematic review. Campbell Systematic Reviews 10:1, pages 1-38.
Crossref
Crossref
Mark A. Ware. 2013. Neuropathic Pain. Neuropathic Pain
249
266
.
. 2013. Neuropathic Pain. Neuropathic Pain
217
314
.
Alexandra Higgins, Sharleen Yuan, Yanqing Wang & Brian D Burrell. (2013) Differential Modulation of Nociceptive versus Non-Nociceptive Synapses by Endocannabinoids. Molecular Pain 9, pages 1744-8069-9-26.
Crossref
Crossref
R. M. Langford, J. Mares, A. Novotna, M. Vachova, I. Novakova, W. Notcutt & S. Ratcliffe. (2012) A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis. Journal of Neurology 260:4, pages 984-997.
Crossref
Crossref
Claire M. Rice & Alastair Wilkins. 2013. Progressive Multiple Sclerosis. Progressive Multiple Sclerosis
147
186
.
Blair H SmithNicola Torrance & Martin Johnson. (2012) Assessment and management of neuropathic pain in primary care. Pain Management 2:6, pages 553-559.
Crossref
Crossref
Abdul Ghaaliq LalkhenJonathan Paul BedfordAlison Devina Dwyer. (2012) Pain associated with multiple sclerosis:epidemiology, classification and management. British Journal of Neuroscience Nursing 8:5, pages 267-274.
Crossref
Crossref
Simon Zhornitsky & Stéphane Potvin. (2012) Cannabidiol in Humans—The Quest for Therapeutic Targets. Pharmaceuticals 5:5, pages 529-552.
Crossref
Crossref
David Baker, Gareth Pryce, Samuel J. Jackson, Chris Bolton & Gavin Giovannoni. (2012) The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis. Multiple Sclerosis and Related Disorders 1:2, pages 64-75.
Crossref
Crossref
Aldric Hama & Jacqueline Sagen. (2012) Combination Drug Therapy for Pain following Chronic Spinal Cord Injury. Pain Research and Treatment 2012, pages 1-13.
Crossref
Crossref
Andrew J. Hill, Claire M. Williams, Benjamin J. Whalley & Gary J. Stephens. (2012) Phytocannabinoids as novel therapeutic agents in CNS disorders. Pharmacology & Therapeutics 133:1, pages 79-97.
Crossref
Crossref
Aoife Gowran, Janis Noonan & Veronica A. Campbell. (2011) The Multiplicity of Action of Cannabinoids: Implications for Treating Neurodegeneration. CNS Neuroscience & Therapeutics 17:6, pages 637-644.
Crossref
Crossref
Aldric Hama & Jacqueline Sagen. (2011) Centrally mediated antinociceptive effects of cannabinoid receptor ligands in rat models of nociception. Pharmacology Biochemistry and Behavior 100:2, pages 340-346.
Crossref
Crossref
Judith A. Paice & Betty Ferrell. (2011) The management of cancer pain. CA: A Cancer Journal for Clinicians 61:3, pages 157-182.
Crossref
Crossref
Jimena Fiz, Marta Durán, Dolors Capellà, Jordi Carbonell & Magí Farré. (2011) Cannabis Use in Patients with Fibromyalgia: Effect on Symptoms Relief and Health-Related Quality of Life. PLoS ONE 6:4, pages e18440.
Crossref
Crossref
Sara N. Davison & Joseph S. Davison. (2011) Is There a Legitimate Role for the Therapeutic Use of Cannabinoids for Symptom Management in Chronic Kidney Disease?. Journal of Pain and Symptom Management 41:4, pages 768-778.
Crossref
Crossref
John P. Zajicek & Vicentiu I. Apostu. (2011) Role of Cannabinoids in Multiple Sclerosis. CNS Drugs 25:3, pages 187-201.
Crossref
Crossref
ELIZABETH C. TEMPLE, RHONDA F. BROWN & DONALD W. HINE. (2011) THE GRASSY KNOLL . . . AND AN ELEPHANT. Addiction 106:2, pages 251-252.
Crossref
Crossref
Alan J Thompson, Ahmed T Toosy & Olga Ciccarelli. (2010) Pharmacological management of symptoms in multiple sclerosis: current approaches and future directions. The Lancet Neurology 9:12, pages 1182-1199.
Crossref
Crossref
Sue Peat. (2010) Using cannabinoids in pain and palliative care. International Journal of Palliative Nursing 16:10, pages 481-485.
Crossref
Crossref
Samir K. Ballas. (2010) New era dawns on sickle cell pain. Blood 116:3, pages 311-312.
Crossref
Crossref
Emma L Scotter, Mary E Abood & Michelle Glass. (2010) The endocannabinoid system as a target for the treatment of neurodegenerative disease. British Journal of Pharmacology 160:3, pages 480-498.
Crossref
Crossref
Kenneth R. Goldschneider & Anne W. Lucky. (2010) Pain Management in Epidermolysis Bullosa. Dermatologic Clinics 28:2, pages 273-282.
Crossref
Crossref
Igor Kissin. (2010) The Development of New Analgesics Over the Past 50 Years: A Lack of Real Breakthrough Drugs. Anesthesia & Analgesia 110:3, pages 780-789.
Crossref
Crossref
Eva Martín-Sánchez, Toshiaki A. Furukawa, Julian Taylor & Jose Luis R. Martin. (2009) Systematic Review and Meta-analysis of Cannabis Treatment for Chronic Pain. Pain Medicine 10:8, pages 1353-1368.
Crossref
Crossref
Elizabeth J. Rahn & Andrea G. Hohmann. (2009) Cannabinoids as pharmacotherapies for neuropathic pain: From the bench to the bedside. Neurotherapeutics 6:4, pages 713-737.
Crossref
Crossref
Philip W. Brownjohn & John C. Ashton. (2009) Novel targets in pain research: The case for CB2 receptors as a biorational pain target. Current Anaesthesia & Critical Care 20:5-6, pages 198-203.
Crossref
Crossref
MacDonald J. ChristieChristophe Mallet. (2009) Endocannabinoids Can Open the Pain Gate. Science Signaling 2:88.
Crossref
Crossref
. (2009) Pharmacological Management of Persistent Pain in Older Persons. Pain Medicine 10:6, pages 1062-1083.
Crossref
Crossref
. (2009) Pharmacological Management of Persistent Pain in Older Persons. Journal of the American Geriatrics Society 57:8, pages 1331-1346.
Crossref
Crossref
Antonella Conte, Chiara Marini Bettolo, Emanuela Onesti, Vittorio Frasca, Elisa Iacovelli, Francesca Gilio, Elena Giacomelli, Maria Gabriele, Massimiliano Aragona, Valentina Tomassini, Patrizia Pantano, Carlo Pozzilli & Maurizio Inghilleri. (2012) Cannabinoid‐induced effects on the nociceptive system: A neurophysiological study in patients with secondary progressive multiple sclerosis. European Journal of Pain 13:5, pages 472-477.
Crossref
Crossref
Fernando Caudevilla Gálligo & Antonio Cabrera Majada. (2009) Novedades sobre el cannabis. FMC - Formación Médica Continuada en Atención Primaria 16:4, pages 204-212.
Crossref
Crossref
Jennifer Stinson & Elizabeth Bruce. 2009. Managing Pain in Children. Managing Pain in Children
145
170
.
Teresa Iuvone, Giuseppe Esposito, Daniele De Filippis, Caterina Scuderi & Luca Steardo. (2009) Cannabidiol: A Promising Drug for Neurodegenerative Disorders?. CNS Neuroscience & Therapeutics 15:1, pages 65-75.
Crossref
Crossref
. (2009) Current World Literature. Current Opinion in Supportive & Palliative Care 3:1, pages 79-89.
Crossref
Crossref
W Paul Farquhar-Smith. (2009) Do cannabinoids have a role in cancer pain management?. Current Opinion in Supportive & Palliative Care 3:1, pages 7-13.
Crossref
Crossref
Vincent KF Kong & Michael G Irwin. (2009) Adjuvant analgesics in neuropathic pain. European Journal of Anaesthesiology 26:2, pages 96-100.
Crossref
Crossref
Janet Weber, Marcus Schley, Matthias Casutt, Helmut Gerber, Guido Schuepfer, Roman Rukwied, Wolfgang Schleinzer, Michael Ueberall & Christoph Konrad. (2009) Tetrahydrocannabinol (Delta 9-THC) Treatment in Chronic Central Neuropathic Pain and Fibromyalgia Patients: Results of a Multicenter Survey. Anesthesiology Research and Practice 2009, pages 1-9.
Crossref
Crossref
Victoria Chapman, David Kendall & Devi Rani Sagar. 2009. Synaptic Plasticity in Pain. Synaptic Plasticity in Pain
337
351
.
Zuzana Justinova, Regina A. Mangieri, Marco Bortolato, Svetlana I. Chefer, Alexey G. Mukhin, Jason R. Clapper, Alvin R. King, Godfrey H. Redhi, Sevil Yasar, Daniele Piomelli & Steven R. Goldberg. (2008) Fatty Acid Amide Hydrolase Inhibition Heightens Anandamide Signaling Without Producing Reinforcing Effects in Primates. Biological Psychiatry 64:11, pages 930-937.
Crossref
Crossref
Rita Lenk & Rudolf Likar. (2008) Cannabinoide in der MedizinCannabinoids in Medicine. Wiener Medizinische Wochenschrift 158:23-24, pages 668-673.
Crossref
Crossref
S Maione, E Morera, I Marabese, A Ligresti, L Luongo, G Ortar & V Di Marzo. (2008) Antinociceptive effects of tetrazole inhibitors of endocannabinoid inactivation: cannabinoid and non-cannabinoid receptor-mediated mechanisms. British Journal of Pharmacology 155:5, pages 775-782.
Crossref
Crossref
R.D. Hosking & J.P. Zajicek. (2008) Therapeutic potential of cannabis in pain medicine. British Journal of Anaesthesia 101:1, pages 59-68.
Crossref
Crossref
S. A. Wolf & O. Ullrich. (2008) Endocannabinoids and the Brain Immune System: New Neurones at the Horizon?. Journal of Neuroendocrinology 20:s1, pages 15-19.
Crossref
Crossref
Stephen I. Deutsch, Richard B. Rosse, Julie M. Connor, Jessica A. Burket, Mary E. Murphy & Fiona J. Fox. (2014) Current Status of Cannabis Treatment of Multiple Sclerosis with an Illustrative Case Presentation of a Patient with MS, Complex Vocal Tics, Paroxysmal Dystonia, and Marijuana Dependence Treated with Dronabinol. CNS Spectrums 13:5, pages 393-403.
Crossref
Crossref
Christopher Hebbes & David Lambert. (2008) Non-opioid analgesic drugs. Anaesthesia & Intensive Care Medicine 9:2, pages 79-83.
Crossref
Crossref
Gareth Pryce, Sam J. Jackson & David Baker. 2008. Cannabinoids and the Brain. Cannabinoids and the Brain
375
394
.
Turo J. Nurmikko, Mick G. Serpell, Barbara Hoggart, Peter J. Toomey, Bart J. Morlion & Derek Haines. (2007) Sativex successfully treats neuropathic pain characterised by allodynia: A randomised, double-blind, placebo-controlled clinical trial. Pain 133:1, pages 210-220.
Crossref
Crossref
D Baker, S J Jackson & G Pryce. (2009) Cannabinoid control of neuroinflammation related to multiple sclerosis. British Journal of Pharmacology 152:5, pages 649-654.
Crossref
Crossref
Koen Van Laere. (2007) In vivo imaging of the endocannabinoid system: a novel window to a central modulatory mechanism in humans. European Journal of Nuclear Medicine and Molecular Imaging 34:11, pages 1719-1726.
Crossref
Crossref
H. S. Brand. (2007) Adverse effects from a cannabis spray. British Dental Journal 203:6, pages 336-337.
Crossref
Crossref
Thomas W. Klein & Catherine A. Newton. 2007. Immune-Mediated Diseases. Immune-Mediated Diseases
395
413
.